BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 12408818)

  • 1. Control of Smad7 stability by competition between acetylation and ubiquitination.
    Grönroos E; Hellman U; Heldin CH; Ericsson J
    Mol Cell; 2002 Sep; 10(3):483-93. PubMed ID: 12408818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
    Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
    J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane.
    Suzuki C; Murakami G; Fukuchi M; Shimanuki T; Shikauchi Y; Imamura T; Miyazono K
    J Biol Chem; 2002 Oct; 277(42):39919-25. PubMed ID: 12151385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
    Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
    EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance between acetylation and deacetylation controls Smad7 stability.
    Simonsson M; Heldin CH; Ericsson J; Grönroos E
    J Biol Chem; 2005 Jun; 280(23):21797-803. PubMed ID: 15831498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
    Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
    J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
    Liu X; Nagarajan RP; Vale W; Chen Y
    FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
    Kavsak P; Rasmussen RK; Causing CG; Bonni S; Zhu H; Thomsen GH; Wrana JL
    Mol Cell; 2000 Dec; 6(6):1365-75. PubMed ID: 11163210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
    Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
    Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
    Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
    Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
    J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
    Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A
    J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
    Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
    Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain.
    Ogunjimi AA; Briant DJ; Pece-Barbara N; Le Roy C; Di Guglielmo GM; Kavsak P; Rasmussen RK; Seet BT; Sicheri F; Wrana JL
    Mol Cell; 2005 Aug; 19(3):297-308. PubMed ID: 16061177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation.
    Jin YH; Jeon EJ; Li QL; Lee YH; Choi JK; Kim WJ; Lee KY; Bae SC
    J Biol Chem; 2004 Jul; 279(28):29409-17. PubMed ID: 15138260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-beta signaling by Smad7.
    Tajima Y; Goto K; Yoshida M; Shinomiya K; Sekimoto T; Yoneda Y; Miyazono K; Imamura T
    J Biol Chem; 2003 Mar; 278(12):10716-21. PubMed ID: 12519765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.